Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
US Department of Justice

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 7,304,033

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,304,033
Title:Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
Abstract: The present invention is a method of inhibiting islet cell transplant rejection, particularly to treat diabetes, such as type-1 and type-2 diabetes, by administering to a subject an effective amount of a soluble CTLA4 mutant molecule. One example of a soluble CTLA4 mutant molecule is L104EA29YIg.
Inventor(s): Larsen; Christian P. (Atlanta, GA), Pearson; Thomas C. (Atlanta, GA), Adams; Andrew B. (Atlanta, GA), Peach; Robert J. (San Diego, CA), Linsley; Peter S. (Seattle, WA), Naemura; Joseph Roy (Bellevue, WA), Bajorath; Jurgen (Bonn, DE)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:10/155,514
Patent Claims:see list of patent claims

Details for Patent 7,304,033

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bayer Healthcare Pharms BETASERON interferon beta-1b VIAL; SUBCUTANEOUS 103471 001 1993-07-23   Try a Free Trial Bristol-Myers Squibb Company (Princeton, NJ) 2021-05-23 RX Orphan search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17   Try a Free Trial Bristol-Myers Squibb Company (Princeton, NJ) 2021-05-23 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 001 1998-05-12   Try a Free Trial Bristol-Myers Squibb Company (Princeton, NJ) 2021-05-23 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.